APA Alıntı

Xu, J., Xu, N., Bai, Y., Liu, R., Mao, C., Sui, H., . . . Dou, Y. (2020). Anti-PD-1 antibody HX008 combined with oxaliplatin plus capecitabine for advanced gastric or esophagogastric junction cancer: A multicenter, single-arm, open-label, phase Ib trial. Oncoimmunology.

Chicago Stili Alıntı

Xu, Jianming, Nong Xu, Yuxian Bai, Rongrui Liu, Chenyu Mao, Hong Sui, Xiaofei Wang, Qian Jiang, ve Yiwei Dou. "Anti-PD-1 Antibody HX008 Combined With Oxaliplatin Plus Capecitabine for Advanced Gastric or Esophagogastric Junction Cancer: A Multicenter, Single-arm, Open-label, Phase Ib Trial." Oncoimmunology 2020.

MLA Alıntı

Xu, Jianming, et al. "Anti-PD-1 Antibody HX008 Combined With Oxaliplatin Plus Capecitabine for Advanced Gastric or Esophagogastric Junction Cancer: A Multicenter, Single-arm, Open-label, Phase Ib Trial." Oncoimmunology 2020.